Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography.
<h4>Introduction</h4>Metabolic syndrome (MS) is characterized by dyslipidemia, central obesity, hypertension and hyperglycemia. However, type 2 diabetes mellitus (T2DM) may or may not be present in metabolic syndrome. MS and T2DM are considered important cardiovascular risk factors, but...
Saved in:
| Main Authors: | Beatriz Dal Santo Francisco Bonamichi, Erika Bezerra Parente, Ana Carolina Noronha Campos, Adriano Namo Cury, João Eduardo Nunes Salles |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171733&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Intracoronary Imaging in Acute Coronary Syndromes
by: Gregory Petrossian, et al.
Published: (2022-06-01) -
The Value of Intracoronary Imaging and Coronary Physiology When Treating Calcified Lesions
by: Yasushi Ueki, et al.
Published: (2019-11-01) -
Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease
by: Benita Tjoe, et al.
Published: (2025-05-01) -
Microcosting analysis of percutaneous coronary intervention with and without intracoronary imaging in an Irish tertiary referral centre
by: Catherine McGorrian, et al.
Published: (2025-02-01) -
Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease
by: Ji Young Park, et al.
Published: (2022-01-01)